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Background: Positron emission tomography (PET) allows for the measurement of cerebral blood flow (CBF; based
on [15O]H2O) and cerebral metabolic rate of glucose utilization (CMRglu; based on [
18 F]-2-fluoro-2-deoxy-D-glucose
([18 F]FDG)). By using kinetic modeling, quantitative CBF and CMRglu values can be obtained. However, hardware
limitations led to the development of semiquantitive calculation schemes which are still widely used. In this paper,
the analysis of CMRglu and CBF scans, acquired on a current state-of-the-art PET brain scanner, is presented. In
particular, the correspondence between nonlinear as well as linearized methods for the determination of CBF and
CMRglu is investigated. As a further step towards widespread clinical applicability, the use of an image-derived input
function (IDIF) is investigated.
Methods: Thirteen healthy male volunteers were included in this study. Each subject had one scanning session in
the fasting state, consisting of a dynamic [15O]H2O scan and a dynamic [
18 F]FDG PET scan, acquired at a high-
resolution research tomograph. Time-activity curves (TACs) were generated for automatically delineated and for
manually drawn gray matter (GM) and white matter regions. Input functions were derived using on-line arterial
blood sampling (blood sampler derived input function (BSIF)). Additionally, the possibility of using carotid artery
IDIFs was investigated. Data were analyzed using nonlinear regression (NLR) of regional TACs and parametric
methods.
Results: After quality control, 9 CMRglu and 11 CBF scans were available for analysis. Average GM CMRglu values
were 0.33 ± 0.04 μmol/cm3 per minute, and average CBF values were 0.43 ± 0.09 mL/cm3 per minute. Good
correlation between NLR and parametric CMRglu measurements was obtained as well as between NLR and
parametric CBF values. For CMRglu Patlak linearization, BSIF and IDIF derived results were similar. The use of an IDIF,
however, did not provide reliable CBF estimates.
Conclusion: Nonlinear regression analysis, allowing for the derivation of regional CBF and CMRglu values, can be
applied to data acquired with high-spatial resolution current state-of-the-art PET brain scanners. Linearized models,
applied to the voxel level, resulted in comparable values. CMRglu measurements do not require invasive arterial
sampling to define the input function.
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Positron emission tomography (PET) measurements
using [18 F]-2-fluoro-2-deoxy-D-glucose ([18 F]FDG)
allow for quantitative determination of the cerebral
metabolic rate of glucose utilization (CMRglu) [1,2]. Al-
though, initially, rate constants were measured [3-5]
using the compartment model developed by Sokoloff
and co-workers [6], thereafter, CMRglu measurements
were increasingly based on the assumption of fixed rate
constants in combination with static scans [7]. As a re-
sult, no recent estimates of the rate constants obtained
using a state-of-the-art high-resolution scanner are avail-
able for human studies (estimates have only been
reported for mice; see [8]).
Quantification of regional cerebral blood flow (CBF)
based on [15O]H2O and PET also started around the
same time period as metabolic assessments, i.e., around
1980. Due to hardware limitations, scanners were too
slow for fast dynamic scans, leading to steady-state [9]
and autoradiographic protocols [10]. Dynamic scan pro-
tocols were not introduced until the late 1980s [11,12],
but to date, relatively few methodological papers on fully
dynamic implementations have been published. In a re-
view by Silverman and Phelps, it was noted that CBF
measurements showed more variability than CMRglu
measurements with standard deviations within investiga-
tions of around 10% to 20% and up to 100% between
investigations [13].
The high-resolution research tomograph (HRRT; CTI/
Siemens, Knoxville, TN, USA) is a dedicated brain scan-
ner that combines high spatial resolution (approximately
3 mm) with good sensitivity [14]. Previously, it has been
shown that the increased spatial resolution allows for
measurements of CMRglu with reduced underestimation
due to partial volume effects [15,16]. These glucose mea-
surements, however, were based on a static FDG proto-
col together with population average-based values for
the rate constants. In a recent study, HRRT image qual-
ity was shown to be good enough to allow for quantita-
tively correct CBF measurements [17].
The use of an arterial line (blood sampler derived in-
put function (BSIF) to acquire an input function is the
gold standard for dynamic data analysis of cerebral stud-
ies, but it is an invasive procedure. Therefore, use of an
image-derived input function (IDIF) can be an interest-
ing alternative [18-20], but its utility needs to be vali-
dated for each tracer, each scanner, and each acquisition
and data analysis protocol separately.
The main purpose of the present study was to derive
human CBF and CMRglu values as measured using a
current state-of-the-art high-resolution scanner. Data
were analyzed by full kinetic analysis using nonlinear re-
gression (NLR) of regional time-activity curve (TAC)
data with a BSIF. A second objective was to assess theaccuracy of high-resolution parametric images of CBF
and CMRglu. In addition, CBF and Ki values for automat-
ically delineated regions were compared with manually
drawn regions of interest and literature values. Based on
earlier work on IDIFs [18,20,21] and given the high reso-
lution of the HRRT, an additional objective was to assess
whether a carotid artery-based IDIF could be used as a
noninvasive alternative for arterial sampling in the case
of both CBF and CMRglu measurements, thereby in-
creasing clinical applicability of this methodology in
humans.
Methods
Healthy subjects and study design
Thirteen healthy men (age 36.2 ± 13.2 years, body mass
index 25.8 ± 3.7 kg/m2, arterial plasma glucose 5.5 ±
0.2 mmol/L) participated in this study. The study con-
sisted of a screening visit and two visits for magnetic
resonance imaging (MRI) and PET scan acquisition, re-
spectively. All subjects were free of medical and psychi-
atric illness based on medical history, physical
examination, and blood analysis. All subjects provided
written informed consent prior to inclusion. The study
was approved by the Medical Ethics Review Committee
of the VU University Medical Center and the Central
Committee on Research Involving Human Subjects; the
study was conducted according to the Declaration of
Helsinki.
Scan protocol
One week prior to the PET study, 3-D structural MRI
images were acquired using a 3.0 T GE Signa HDxt MRI
scanner (General Electric, Milwaukee, WI, USA) and a
T1-weighted fast spoiled gradient echo sequence. Data
consisted of 172 planes of 256 × 256 voxels with a voxel
size of 0.94 × 0.94 × 1 mm3.
At the day of the PET study, catheters were placed in
the antecubital vein for tracer injection and in the radial
artery for blood sampling. Next, subjects were posi-
tioned on the HRRT scanner bed such that the head was
in the center of the field of view. Velcro tapes were used
to minimize patient movement during the entire im-
aging procedure. Lights were dimmed, noise was mini-
mized, and subjects were asked to close their eyes and
stay awake during data acquisition. Prior to or immedi-
ately after the [15O]H2O scan, a 6-min singles-based
transmission scan with a fan-collimated 137Cs moving
point source was acquired. A 10-min dynamic emission
scan was started 10 s prior to a bolus injection of ap-
proximately 800 MBq [15O]H2O. Radioactivity was con-
tained within a volume of approximately 5 mL and was
followed by a saline flush to give a total injected volume
of 40 mL, administered at a rate of 2 mL/s using an infu-
sion pump (Medrad Inc., Indianola, MS, USA). To allow
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acquired after an interval of at least 10 min following
the [15O]H2O scan. A 60-min dynamic emission scan
was started 30 s prior to a bolus injection of 186 ±
9 MBq [18 F]FDG. The administration protocol was iden-
tical to the one used for the [15O]H2O scan. During both
emission scans, arterial blood concentrations were moni-
tored continuously using a dedicated on-line blood sam-
pler (Veenstra Instruments, Joure, Netherlands [22]).
During the first 4 min of the [15O]H2O scan, blood was
withdrawn at a rate of 450 mL/h and activity was read
out once per second. For the remaining 6 min, the with-
drawal rate was reduced to 150 mL/h and the readout
sampling time increased to 10 s. In addition, three
manual blood samples were taken at 5, 7.5, and 9 min
post-injection. These samples were taken from the same
arterial line by briefly interrupting continuous with-
drawal. After each sample, the arterial line was flushed
with heparinized saline to prevent clotting. Manual sam-
ples were used to measure whole blood radioactivity con-
centrations. The sampling procedure during the [18 F]
FDG scan was similar to that of the [15O]H2O scan but
with withdrawal rates of 300 mL/h during the first 5 min
and 150 mL/h thereafter. During this scan, manual blood
samples were taken 15, 35, and 55 min post-injection.
These samples were used to measure both whole blood
and plasma radioactivity concentrations, as well as arter-
ial plasma glucose levels. This BSIF was used in all ana-
lyses except for analyses based on an IDIF.
Data reconstruction
Emission data were histogrammed into multiframe sino-
grams ([15O]H2O 14 fames of 6 × 10, 2 × 30, 4 × 60, and
2 × 120 s; [18 F]FDG 19 frames of 6 × 10, 2 × 30, 3 × 60,
2 × 150, 2 × 300, and 4 × 600 s). Sinograms were normal-
ized, corrected for randoms, dead time, and decay, and
based on the transmission scan corrected for scatter and
attenuation. Corrected sinograms were reconstructed
using the iterative 3D ordinary Poisson ordered subset
expectation maximization algorithm [23,24] using eight
iterations and 16 subsets. Reconstructed images con-
sisted of 207 planes of 256 × 256 voxels with a voxel size
of 1.22 × 1.22 × 1.22 mm3.
Regions of interest definition
The MRI image was co-registered with either a corre-
sponding summed [18 F]FDG (15 to 60 min) or [15O]
H2O (0 to 90 s) image using the software package VINCI
[25]. Both PET and MRI images were rebinned and
cropped into 128 × 128 × 63 matrices with an isotropic
voxel dimension of 2.44 mm. Automatic delineation of
regions of interest (ROIs) was performed using PVElab
[26] resulting in a total of 17 gray matter regions, subdi-
vided into their left and right constituents (cerebellarcortex, orbital frontal cortex, inferior medial frontal cor-
tex, anterior cingulate cortex, thalamus, insula, caudate
nucleus, putamen, superior temporal cortex, parietal
cortex, inferior medial temporal cortex, superior frontal
cortex, occipital cortex, sensory motor cortex, posterior
cingulate cortex, enthorinal cortex, and hippocampus), a
global white matter (WM) region, and a total gray mat-
ter (GM) region. To compare our data to literature
values, two additional manually drawn ROIs were ana-
lyzed: a gray matter region (insular gray in four succes-
sive transversal planes) and a white matter region
(centrum semiovale in two successive transversal planes),
using Amide [27]. Corresponding TACs were generated
by projecting these ROIs onto the dynamic image
sequences.Calculation of CMRglu
Sampler data were corrected for flushes and calibrated
using the plasma concentrations derived from the three
manual samples per subject to generate an arterial
plasma input function. First, using NLR, TACs were fit-
ted to the standard irreversible two-tissue compartment
model, providing the three rate constants K1, k2, and k3
as well as the blood volume fraction VB. Second, the val-
idity of the Patlak linearization [28] was investigated by
comparing regional values of the net influx rate constant
Ki with those obtained using NLR. Third, the Patlak
method was used (without smoothing) on a voxel-by-
voxel basis, and for each ROI, mean values extracted
from parametric Ki images were compared with those
obtained from regional Patlak analyses. Additionally,
parametric images were smoothed with a 6-mm Gauss-
ian filter (typical resolution of the current-generation
whole-body PET scanners) prior to analysis. CMRglu was
calculated as Ki times arterial plasma glucose divided by
a lumped constant of 0.52 [29].Calculation of CBF
Whole blood input functions as well as regional TACs
were derived as described above. First, TACs were fitted
to the standard single-tissue compartment model, fixing
delay and dispersion to the values obtained from a fit to
the whole brain TAC [12], providing CBF as well as VT,
distribution volume. Second, after smoothing with a
6-mm Gaussian filter, this analysis was repeated, and in
addition, parametric CBF images were generated using a
basis function method (BFM) implementation of the
blood flow model [30]. For each ROI, mean parametric
CBF was compared with the corresponding value from
the regional analysis. The FDG extraction fraction was
calculated from combined CBF and CMRglu data as K1 =
E · CBF.
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BSIFs are invasive, and therefore, the use of IDIFs was
investigated. For FDG, arterial activity was clearly seen
after smoothing an early frame (approximately 20 to
30 s post-injection) with a 6-mm Gaussian filter. Starting
three planes below the circle of Willis to avoid contam-
ination with activity from the brain, ten successive
planes were combined into an ROI representing a ca-
rotid artery [18,19]. The four hottest pixels per plane
were identified and combined in a carotid artery ROI.
The average time-activity curve obtained from the two
carotid artery ROIs, scaled to the manual samples, was
taken as the whole blood IDIF. A plasma IDIF was
obtained by multiplying the whole blood IDIF with the
average plasma-to-whole blood ratio derived from the
samples. For [15O]H2O, an identical procedure was
followed.
Results and discussion
Results
[18 F]FDG scans were acquired in all 13 subjects and
[15O]H2O scans in 12 subjects (at one occasion, no
[15O]H2O was available). Analysis of one [
18 F]FDG scan
failed due to sampling problems, and two [18 F]FDG
scans were discarded because of movement artifacts.
Due to technical problems, [18 F]FDG and [15O]H2O
data could not be obtained for one subject. Overall, 9
complete [18 F]FDG and 11 complete [15O]H2O data setsTable 1 Regional CMRglu, K1, CBF, VT, and E values obtained i
Region CMRglu K1
Cerebellum 0.24 ± 0.03 (11) 0.075 ± 0.011
Orbitofrontal cortex 0.34 ± 0.04 (10) 0.065 ± 0.010
Medial inferior frontal cortex 0.39 ± 0.03 (8) 0.073 ± 0.012
Cingulate anterior 0.30 ± 0.04 (12) 0.065 ± 0.009
Thalamus 0.36 ± 0.04 (11) 0.082 ± 0.018
Insula 0.33 ± 0.03 (10) 0.069 ± 0.007
Caudate nucleus 0.38 ± 0.04 (11) 0.067 ± 0.011
Putamen 0.41 ± 0.04 (10) 0.076 ± 0.013
Superior temporal cortex 0.33 ± 0.03 (8) 0.064 ± 0.008
Parietal cortex 0.37 ± 0.02 (6) 0.072 ± 0.009
Medial inferior temporal cortex 0.31 ± 0.03 (11) 0.059 ± 0.007
Superior frontal cortex 0.36 ± 0.03 (8) 0.069 ± 0.009
Occipital cortex 0.35 ± 0.03 (7) 0.067 ± 0.007
Sensorimotor cortex 0.34 ± 0.02 (6) 0.068 ± 0.009
Cingulate posterior 0.41 ± 0.03 (8) 0.079 ± 0.013
Enthorinale 0.19 ± 0.08 (44) 0.047 ± 0.014
Hippocampus 0.22 ± 0.04 (16) 0.057 ± 0.011
White matter 0.19 ± 0.01 (7) 0.046 ± 0.00
Total gray matter 0.29 ± 0.03 (8) 0.062 ± 0.006
Mean ± SD (CoV); data are obtained by NLR analysis based on BSIFs. CMRglu, cerebra
rate constant from blood to tissue (in min-1 (n = 9)); CBF, cerebral blood flow (in mL
measurements (n = 11)); E, FDG extraction fraction (in % (n = 8)).were available for analysis, and 8 combined data sets
could be used for the calculation of the FDG extraction
fraction.
CMRglu
No significant differences between left and right CMRglu
values were observed for any of the regions delineated
automatically. Average (left and right) CMRglu values are
listed in Table 1. Total gray matter CMRglu was 0.29 ±
0.03 μmol/cm3 per minute, and white matter CMRglu
was 0.19 μmol/cm3 per minute (ratio GM/WM= 1.5).
Excluding the entorhinal cortex, an average coefficient
of variation (CoV) of 10.0% was observed. The high CoV
in the entorhinal cortex is probably due to the small vol-
ume of this region (3.4 ± 0.4 mL), and this region was
excluded from the further analyses. A typical blood vol-
ume fraction,VB, of 0.05 ± 0.01 was obtained.
Manually drawn ROIs resulted in CMRglu values of
0.33 and 0.11 μmol/cm3 per minute for gray matter and
white matter, respectively (ratio GM/WM= 3.0). In
Table 2, mean values of the separate rate constants for
these manual ROIs are listed as well as a comparison
with literature data in which similar types of ROIs were
used; no recent papers were available for comparison of
these separate parameters.
Figure 1 shows the (linear) relationship between
Patlak- and NLR-derived Ki values for the 16 (automatic)
combined gray matter regions and a white matter region.n healthy males
CBF VT E
(15) 0.36 ± 0.07 (19) 0.71 ± 0.08 (11) 21 ± 2 (11)
(15) 0.42 ± 0.07 (17) 0.69 ± 0.05 (7) 16 ± 2 (14)
(16) 0.42 ± 0.06 (13) 0.71 ± 0.05 (7) 17 ± 3 (15)
(14) 0.37 ± 0.05 (13) 0.69 ± 0.05 (8) 17 ± 3 (16)
(22) 0.46 ± 0.06 (13) 0.74 ± 0.05 (7) 19 ± 3 (16)
(11) 0.45 ± 0.07 (15) 0.76 ± 0.05 (7) 16 ± 2 (10)
(16) 0.39 ± 0.06 (16) 0.68 ± 0.07 (10) 18 ± 3 (17)
(17) 0.47 ± 0.08 (16) 0.75 ± 0.07 (9) 17 ± 4 (21)
(13) 0.38 ± 0.04 (11) 0.70 ± 0.05 (7) 17 ± 2 (10)
(12) 0.39 ± 0.05 (12) 0.71 ± 0.05 (7) 19 ± 2 (11)
(13) 0.33 ± 0.05 (15) 0.65 ± 0.06 (10) 18 ± 2 (11)
(13) 0.40 ± 0.06 (14) 0.71 ± 0.05 (7) 17 ± 2 (12)
(10) 0.38 ± 0.05 (14) 0.68 ± 0.07 (10) 18 ± 1 (8)
(13) 0.37 ± 0.04 (12) 0.68 ± 0.05 (7) 19 ± 2 (12)
(16) 0.44 ± 0.06 (13) 0.73 ± 0.05 (7) 19 ± 2 (12)
(30) 0.26 ± 0.05 (18) 0.59 ± 0.08 (14) 18 ± 4 (25)
(19) 0.30 ± 0.04 (14) 0.67 ± 0.07 (10) 19 ± 4 (20)
4 (9) 0.25 ± 0.04 (15) 0.61 ± 0.05 (9) 19 ± 2 (10)
(10) 0.35 ± 0.05 (14) 0.64 ± 0.05 (8) 18 ± 1 (8)
l metabolic rate of glucose consumption (in μmol/cm3 per minute (n = 9)); K1,
/cm3 per minute (n = 11)); VT, volume of distribution (unitless, obtained by CBF
Table 2 Rate constants of FDG parameters for manually drawn gray and white matter ROIs and literature values
FDG parameters
Ki K1 K2 k3 k4
Present study (3 K)
GM 0.031 ± 0.004 0.062 ± 0.008 0.071 ± 0.04 0.067 ± 0.03 n/a
WM 0.010 ± 0.0008 0.033 ± 0.004 0.083 ± 0.03 0.037 ± 0.01 n/a
GM/WM 3.0 1.9 0.87 1.8 n/a
Huang et al. (4 K) [3]
GM 0.0334 ± 0.006 0.102 ± 0.03 0.13 ± 0.07 0.062 ± 0.02 0.0068 ± 0.001
WM 0.0154 ± 0.004 0.054 ± 0.01 0.109 ± 0.04 0.045 ± 0.02 0.0058 ± 0.002
GM/WM 2.2 1.9 1.2 1.4 1.2
Reivich et al. (3 K) [29]
GM 0.035a 0.105 ± 0.006 0.148 ± 0.008 0.074 ± 0.005 n/a
WM 0.023a 0.069 ± 0.005 0.129 ± 0.004 0.064 ± 0.006 n/a
GM/WM 1.5 1.5 1.1 1.2 n/a
Reivich et al. (4 K) [29]
GM 0.034a 0.095 ± 0.005 0.125 ± 0.002 0.069 ± 0.002 0.0055 ± 0.0003
WM 0.022a 0.065 ± 0.005 0.126 ± 0.003 0.066 ± 0.002 0.0054 ± 0.0006
GM/WM 1.5 1.5 0.99 1.0 1.0
Mean ± SD; data of the present study are obtained by NLR analyses based on BSIFs. 3 K, 3 k model (i.e., k4 = 0); 4 K, 4 k parameter model; Ki, net influx rate
(in min-1); K1, rate of transport from blood to brain (in min
-1); k2, rate of transport from brain to blood (in min
-1); k3, phosphorylation rate by hexokinase
(in min-1); k4, rate of hydrolysis by glucose-6-phosphatase (in min
-1); GM, gray matter; WM, white matter; n/a, not applicable. aCalculated by the K1, k2, and k3
parameters reported in the paper.
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0.98.
Based on the good correlation between Patlak and
NLR results, parametric (Patlak) images were generated
without smoothing. Figure 2 shows the relationship be-
tween average parametric and ROI-derived Ki values,
both before and after smoothing of the parametric
images. Without smoothing, a slope of 1.04 and an r2 of
0.99 were obtained. After smoothing, these values were
0.97 and 0.90, respectively.Figure 1 Correlation between Patlak- and NLR-derived
Ki values. Data of all 16 gray matter regions and a white matter
brain region of nine healthy subjects are presented. Data points for
each individual subject are shown with a separate symbol. The solid
line indicates the line of identity.The correlation between average regional NLR and
parametric values had a slope of 1.0 and r2 of 0.90 (data
not shown). A representative parametric image is shown
in Figure 3.
CBF
Average delay and dispersion values were 12 ± 3 and
10 ± 2 s, respectively. CBF values for the variousFigure 2 Correlation of average Ki values derived using
parametric and regional Patlak analyses. Data of all 16 total gray
matter regions and a white matter brain region are presented for
nine subjects. Parametric values represent the mean of all voxels
within an ROI. The solid line indicates the line of identity. Results for
both images without smoothing (black dots) and those smoothed
with a 6-mm Gaussian filter (white dots) are shown.
Table 3 Rate constants of H2O parameters for manually
drawn gray and white matter ROIs and literature values
H2O parameters
CBF VT E
Present study
GM 0.43 ± 0.09 0.72 ± 0.06 15
WM 0.13 ± 0.02 0.69 ± 0.10 26
GM/WM 3.3 1.1 0.6
Walker et al. [17]
GM 0.44 ± 0.03
WM 0.15 ± 0.03
GM/WM 2.9
Mean ± SD; data of the present study are obtained by NLR analyses based on
BSIFs. CBF, cerebral blood flow (in mL/cm3 per minute); VT, volume of
distribution (unitless); E, FDG extraction fraction (in %); GM, gray matter; WM,
white matter.
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given in Table 1. Total gray and white matter CBFs were
0.35 ± 0.05 and 0.25 ± 0.04 mL/cm3 per minute, respect-
ively, (GM:WM= 1.4). Table 3 shows CBF values
obtained from the manually drawn gray and white mat-
ter regions (ratio GM/WM= 3.3) as well as a compari-
son with literature data, recently obtained using another
HRRT scanner [17]. Figure 4 shows the relationship be-
tween CBF values derived from BFM and NLR analyses
on smoothed data. Linear regression provided a slope of
1.02 and an r2 of 0.73. In Figure 3, a representative para-
metric image is presented.
FDG extraction fractions for each ROI are shown in
Table 1. For the total gray matter region, the FDG ex-
traction fraction was 18 ± 1%.
Image-derived input functions
In order to scale the IDIF derived from the [18 F]FDG
scan to the manual samples, a multiplication factor was
derived (average value 2.2 ± 0.5). Figure 5 shows the rela-
tionship between IDIF- and BSIF-derived Ki values for
regional NLR ROI analyses. In two out of nine subjects,
a slope of 0.76 ± 0.09 and r2 of 0.40 ± 0.65 were
observed. For the other seven patients, slope and r2 were
1.03 ± 0.05 and 0.98 ± 0.01, respectively.
Figure 6 shows the results of a similar comparison for
Patlak-derived Ki values. In this case, no apparent out-
liers, either in single fits or complete subjects, were ap-
parent. Slope and r2 were 0.99 ± 0.06 and 0.99 ± 0.007,
respectively.Figure 3 Representative parametric images of a single subject. The CB
same subject are presented. The parametric CBF image was generated afteIn order to scale the IDIF derived from the [15O]H2O
scan to the manual samples, a multiplication factor of
1.8 ± 0.4 (averaged over 11 subjects) was needed. How-
ever, after scaling, a BSIF/IDIF peak ratio of 3.0 ± 1.2
was observed. Therefore, the shape of the IDIF and the
simultaneously measured BSIF did not match, and thus,
an IDIF approach was not possible in this case.
Discussion
To date, no full kinetic analysis of [18 F]FDG data based
on arterial sampling and a dynamic HRRT scanning
protocol in humans has been reported. In the present
study, average CMRglu values of 0.33 and 0.11 μmol/cm
3F image (upper panel) and the CMRglu image (lower panel) of the
r smoothing with a 6-mm Gaussian filter.
Figure 4 Correlation of CBF values derived using parametric
(basis function method) and regional (NLR) analyses. Data of 16
gray matter regions and a white matter region are shown for 11
subjects. Parametric values represent the mean of all voxels within
an ROI. Data points for each individual subject are shown with a
separate symbol. The solid line indicates the line of identity.
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white matter regions, respectively. Automatically deli-
neated regions yielded values of 0.29 and 0.19 μmol/cm3
per minute for gray matter and white matter, respect-
ively, averaged over nine patients with a CoV of less
than 15%. However, especially the white matter estimate
based on the latter method was contaminated with some
gray matter spill in.
Previously, Heiss and co-workers have acquired
CMRglu data on an HRRT scanner [15]. Using fixed rate
constants from the literature, they found similar gray
and white matter CMRglu values with a GM/WM ratio
of 2.7, which is only slightly lower than the present ratio
for manually drawn regions. Therefore, it seems that aFigure 5 Correlation between IDIF- and BSIF-based NLR-derived
Ki values. The correlation is for 16 gray matter regions and a white
matter region. Data points for each individual subject (n = 9) are
shown with the same symbol. The solid line indicates the line of
identity.static scanning protocol, together with fixed rate con-
stants, is a valid approximation of full kinetic modeling
in the case of healthy volunteers. Nevertheless, it should
be noted that the assumption of fixed rate constants
may not be valid in certain clinically relevant patient
populations, such as those having diabetes [31], charac-
terized by a.o. hyperglycemia and hyperinsulinemia
which both affect the blood vessel wall and the perme-
ability surface area product [32], and decreased glucose
metabolism [33]. Furthermore, normal fixed rate con-
stants are not automatically applicable to flow-limited
states [34].
The good correlation between Patlak and NLR
results (slope 0.96, r2 0.98) implies that this linearization
is a valid approach, as shown previously [7]. The under-
estimation of 4% is likely due to the blood volume (5%)
that is taken into account in the NLR analysis, but not
in the Patlak linearization. Parametric Ki images without
smoothing showed good correlation with regional Ki
values (r2 of 0.99) with a slope of 1.04, probably induced
by differences in noise and tissue heterogeneity present
in regional- versus voxel-based TACs. Smoothing the dy-
namic [18 F]FDG images resulted in a lower slope and
poorer correlation, and this is therefore not
recommended.
Average CBF values of 0.43 and 0.13 mL/cm3 per mi-
nute were obtained for manually drawn gray and white
matter regions, respectively. These values are in line
with the recent data acquired on an HRRT by Walker
and co-workers [17], who found values of 0.44 and
0.15 mL/cm3 per minute (Table 3). The good correlation
between BFM and NLR results implies that this
linearization is a valid approach.
We found an FDG extraction fraction of 18%, which is
in line with earlier reported values of approximately 20%Figure 6 Correlation between IDIF- and BSIF-based
Patlak-derived Ki values. The correlation is for 16 gray matter
regions and a white matter region. Data points for each individual
subject (n = 9) are shown with the same symbol. The solid line
indicates the line of identity.
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[36]. To our knowledge, this has not been derived from
a combined CBF and CMRglu (K1) measurement before.
The use of a noninvasive input function, derived from
the carotid arteries, allowed for quantitatively correct
estimates of regional CMRglu when Patlak linearization
was used. In the case of NLR, however, the more strin-
gent requirements placed on the input function (i.e., in
addition to the area under the curve, the detailed shape
of the peak is needed) resulted in good CMRglu estimates
for only seven out of nine subjects and incorrect (with
an average slope of 0.76) estimates in the other two.
Nevertheless, clinical dynamic [18 F]FDG studies without
the need for an arterial line can be performed (on a
voxel-by-voxel basis) by analyzing data using the Patlak
linearization.
Unfortunately, the IDIF approach was not applicable to
the analysis of CBF scans. Scaling to the manual samples
yielded a similar factor as for CMRglu scans, but an
underestimation of the peak was observed (by a factor of
3). Although 15O has a higher positron energy (leading to
an effective spatial resolution of 3.4 in the case of 15O, if
it were 3.0 for 18 F), this is not likely to be the main rea-
son for the underestimation of the peak. Possible expla-
nations will probably include the implementation of
scatter correction as well as the performance of the re-
construction algorithm for highly localized activity distri-
butions, as prevailing in the blood just after the [15O]
H2O bolus. Therefore, optimization of the frame defin-
ition and the use of a point spread function reconstruc-
tion may lead to a better match between BSIF and IDIF.
It is of importance to note that, although the images
used were smoothed 6 mm at FWHM, the IDIF applic-
ability cannot be automatically used for data generated
at other PET scanners. This still needs a validation for
every single tracer, every single scanner, and each acqui-
sition and data analysis protocol separately. The success
of the use of an IDIF depends on the intrinsic spatial
resolution of the scanner, which is often lower than that
of the scanner used in our study, and on the iterative re-
construction algorithm used (e.g., whether or not priors
are included and whether the partial volume effect is
implemented in the reconstruction algorithm), deter-
mining the signal-to-noise ratio as well as the minimum
frame duration that can be applied. Furthermore, the
duration of tracer injection needs to be optimized since
the number of frames that can be acquired during the
bolus should not be too low. The exact effect of these
different options cannot be predicted and needs to be
tested in the way as was described in this paper.
Conclusions
NLR-based regional CMRglu and CBF values can be
obtained using a high-resolution PET brain scanner inhealthy humans. Good correspondence between the
nonlinear and linear models was observed for the re-
gional data, which formed the basis for the calculation
of accurate parametric images. Although no test-retest
study was performed, average inter-subject variability of
approximately 15% was observed, which implies a good
reproducibility. For studies that would only require mea-
surements of CMRglu, regional Patlak-based Ki values
can be derived without arterial sampling by using a
carotid-based image-derived input function.
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